Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies-Reference-Cited by-同舟云学术

Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies

Published:2016-10 Issue: Volume:49 Page:90-97
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Norsworthy Kelly J.,Cho Eunpi,Arora Jyoti,Kowalski Jeanne,Tsai Hua-Ling,Warlick Erica,Showel Margaret,Pratz Keith W.,Sutherland Lesley A.,Gore Steven D.,Ferguson Anna,Sakoian Sarah,Greer Jackie,Espinoza-Delgado Igor,Jones Richard J.,Matsui William H.,Smith B. Douglas

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. New treatment approaches in acute myeloid leukemia: review of recent clinical studies;Norsworthy;Rev. Recent Clin. Trials,2012

2. Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse?;DeZern;Hematology Am. Soc. Hematol. Educ. Program,2015

3. Disruption of differentiation in human cancer: AML shows the way;Tenen;Nat. Rev. Cancer,2003

4. Combined treatment with epigenetic, differentiating, and chemotherapeutic agents cooperatively targets tumor-initiating cells in triple negative breast cancer;Merino;Cancer Res.,2016

5. Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29;Bartolini;Anticancer Res.,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells;Bioorganic & Medicinal Chemistry;2024-02

2. HDAC inhibitors: Promising agents for leukemia treatment;Biochemical and Biophysical Research Communications;2023-11

3. Advances in acute myeloid leukemia differentiation therapy: A critical review;Biochemical Pharmacology;2023-09

4. Immunotherapy in AML: a brief review on emerging strategies;Clinical and Translational Oncology;2021-06-23

5. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy;Frontiers in Cell and Developmental Biology;2020-09-29